Monitoring phase II comparative clinical trials with two endpoints and penalty for adverse events (Q1657815)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Monitoring phase II comparative clinical trials with two endpoints and penalty for adverse events |
scientific article; zbMATH DE number 6917376
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Monitoring phase II comparative clinical trials with two endpoints and penalty for adverse events |
scientific article; zbMATH DE number 6917376 |
Statements
Monitoring phase II comparative clinical trials with two endpoints and penalty for adverse events (English)
0 references
14 August 2018
0 references
bivariate sequences of trials
0 references
clinical trials involving two binary endpoints
0 references
Markov chain embeddable random variables
0 references
phase II clinical trials
0 references
decision rules
0 references
waiting time distribution
0 references
adverse events
0 references
penalization
0 references
0 references
0 references
0.8683943
0 references
0.8579314
0 references
0.8357179
0 references
0.8335169
0 references
